Edwards Lifesciences (NYSE:EW – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Insider and Institutional Ownership 79.3% of Edwards Lifesciences […]
Deal Overview On December 7, 2024, Edwards Lifesciences Corporation (NYSE: EW, $76.90, Market Capitalization: $46.6 billion) in its annual investor call announced its .
Edwards Lifesciences today announced the results of the EU-HYPROTECT registry which indicates that using Acumen HPI software may help reduce the duration and severity of intraoperative hypotension in patients having non-cardiac surgery.
EU-HYPROTECT is a European multicenter prospective observational registry .
CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) and Edwards Lifesciences (NYSE:EW – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Profitability This table compares CellaVision AB (publ) […]
Edwards Lifesciences (NYSE:EW – Get Free Report) and CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Analyst Recommendations This is a summary of […]